Literature DB >> 10855792

VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells.

H Zhang1, Q Wang, K Kajino, M I Greene.   

Abstract

BRCA1, a breast/ovarian cancer susceptibility gene, undergoes mutations in as many as 50% of familial breast tumors. Recent studies indicate that BRCA1 may be involved in DNA damage repair. Here, we demonstrate that the BRCA1 protein physically associates with valosin-containing protein (VCP), a member of the ATPases associated with a variety of cellular activities (AAA) superfamily. In vitro studies revealed that VCP, via its N- terminal region, binds to amino acid residues 303-625 in the BRCA1 protein. Although found predominantly in the cytoplasm and, less abundantly, in the nucleus, VCP can be translocated from the nucleus after stimulation with epidermal growth factor. Collectively, our results suggest that VCP, by binding to BRCA1, participates in the DNA damage-repair function as an ATP transporter, possibly facilitating the transcription-coupled repair.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10855792     DOI: 10.1089/10445490050021168

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  26 in total

1.  ATP-binding sites in brain p97/VCP (valosin-containing protein), a multifunctional AAA ATPase.

Authors:  Ran Zalk; Varda Shoshan-Barmatz
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

2.  Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.

Authors:  H T Zhang; J E Kacharmina; K Miyashiro; M I Greene; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

Authors:  Inês Godet; Daniele M Gilkes
Journal:  Integr Cancer Sci Ther       Date:  2017-02-27

Review 4.  Regulation of molecular chaperones through post-translational modifications: decrypting the chaperone code.

Authors:  Philippe Cloutier; Benoit Coulombe
Journal:  Biochim Biophys Acta       Date:  2013-02-28

Review 5.  Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.

Authors:  Hemmo Meyer; Monika Bug; Sebastian Bremer
Journal:  Nat Cell Biol       Date:  2012-02-02       Impact factor: 28.824

6.  p97 Promotes a Conserved Mechanism of Helicase Unloading during DNA Cross-Link Repair.

Authors:  George Fullbright; Halley B Rycenga; Jordon D Gruber; David T Long
Journal:  Mol Cell Biol       Date:  2016-11-14       Impact factor: 4.272

7.  VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

Authors:  Michael A Gitcho; Jeffrey Strider; Deborah Carter; Lisa Taylor-Reinwald; Mark S Forman; Alison M Goate; Nigel J Cairns
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

8.  Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.

Authors:  Kazi Mokim Ahmed; Connie Y Tsai; Wen-Hwa Lee
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

Review 9.  Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Authors:  Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-04-19       Impact factor: 4.296

10.  DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP.

Authors:  Juneth Joaquin Partridge; Joseph Onofrio Lopreiato; Martin Latterich; Fred Eliezer Indig
Journal:  Mol Biol Cell       Date:  2003-08-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.